Literature DB >> 33716745

The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection.

Mohammad Reza Kalhori1, Fatemeh Saadatpour2, Ehsan Arefian2, Masoud Soleimani3, Mohammad Hosien Farzaei4, Ina Yosifova Aneva5, Javier Echeverría6.   

Abstract

The SARS-CoV-2 virus was reported for the first time in Wuhan, Hubei Province, China, and causes respiratory infection. This pandemic pneumonia killed about 1,437,835 people out of 61,308,161cases up to November 27, 2020. The disease's main clinical complications include fever, recurrent coughing, shortness of breath, acute respiratory syndrome, and failure of vital organs that could lead to death. It has been shown that natural compounds with antioxidant, anticancer, and antiviral activities and RNA interference agents could play an essential role in preventing or treating coronavirus infection by inhibiting the expression of crucial virus genes. This study aims to introduce a summary of coronavirus's genetic and morphological structure and determine the role of miRNAs, siRNAs, chemical drugs, and natural compounds in stimulating the immune system or inhibiting the virus's structural and non-structural genes that are essential for replication and infection of SARS-CoV-2.
Copyright © 2021 Kalhori, Saadatpour, Arefian, Soleimani, Farzaei, Aneva and Echeverría.

Entities:  

Keywords:  SARS-CoV-2; coronavirus; miRNA; natural products; phytochemicals; siRNA

Year:  2021        PMID: 33716745      PMCID: PMC7953353          DOI: 10.3389/fphar.2021.616993

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  159 in total

Review 1.  Arabidopsis endogenous small RNAs: highways and byways.

Authors:  Franck Vazquez
Journal:  Trends Plant Sci       Date:  2006-08-08       Impact factor: 18.313

2.  The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells.

Authors:  Lei Cui; Haiying Wang; Yanxi Ji; Jie Yang; Shan Xu; Xingyu Huang; Zidao Wang; Lei Qin; Po Tien; Xi Zhou; Deyin Guo; Yu Chen
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

3.  miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6.

Authors:  Siyu Wu; Li He; Yuye Li; Tinglong Wang; Lianqiang Feng; Lifang Jiang; Ping Zhang; Xi Huang
Journal:  J Infect       Date:  2013-05-16       Impact factor: 6.072

4.  Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.

Authors:  I-Chueh Huang; Charles C Bailey; Jessica L Weyer; Sheli R Radoshitzky; Michelle M Becker; Jessica J Chiang; Abraham L Brass; Asim A Ahmed; Xiaoli Chi; Lian Dong; Lindsay E Longobardi; Dutch Boltz; Jens H Kuhn; Stephen J Elledge; Sina Bavari; Mark R Denison; Hyeryun Choe; Michael Farzan
Journal:  PLoS Pathog       Date:  2011-01-06       Impact factor: 6.823

Review 5.  Functional and genetic analysis of coronavirus replicase-transcriptase proteins.

Authors:  Stanley G Sawicki; Dorothea L Sawicki; Diane Younker; Yvonne Meyer; Volker Thiel; Helen Stokes; Stuart G Siddell
Journal:  PLoS Pathog       Date:  2005-12-09       Impact factor: 6.823

6.  Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors.

Authors:  Seri Jo; Hyojin Kim; Suwon Kim; Dong Hae Shin; Mi-Sun Kim
Journal:  Chem Biol Drug Des       Date:  2019-09-12       Impact factor: 2.817

7.  Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.

Authors:  Yi Shi; De Hua Yang; Jie Xiong; Jie Jia; Bing Huang; You Xin Jin
Journal:  Cell Res       Date:  2005-03       Impact factor: 25.617

8.  Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies.

Authors:  Rupesh V Chikhale; Vivek K Gupta; Gaber E Eldesoky; Saikh M Wabaidur; Shripad A Patil; Md Ataul Islam
Journal:  J Biomol Struct Dyn       Date:  2020-08-03

9.  Complemented Palindromic Small RNAs First Discovered from SARS Coronavirus.

Authors:  Chang Liu; Ze Chen; Yue Hu; Haishuo Ji; Deshui Yu; Wenyuan Shen; Siyu Li; Jishou Ruan; Wenjun Bu; Shan Gao
Journal:  Genes (Basel)       Date:  2018-09-05       Impact factor: 4.096

10.  Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.

Authors:  Yuanjiang Zhang; Tieshi Li; Ling Fu; Changming Yu; Yinghua Li; Xialian Xu; Yinyin Wang; Hongxiu Ning; Shuping Zhang; Wei Chen; Lorne A Babiuk; Zhijie Chang
Journal:  FEBS Lett       Date:  2004-02-27       Impact factor: 4.124

View more
  6 in total

1.  Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic.

Authors:  Jia-Bo Wang; Adolfo Andrade-Cetto; Javier Echeverria; Jon Wardle; Hung-Rong Yen; Michael Heinrich
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

2.  Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.

Authors:  Maik Friedrich; Gabriele Pfeifer; Stefanie Binder; Achim Aigner; Philippe Vollmer Barbosa; Gustavo R Makert; Jasmin Fertey; Sebastian Ulbert; Jochen Bodem; Eva-Maria König; Nina Geiger; Axel Schambach; Erik Schilling; Tilo Buschmann; Sunna Hauschildt; Ulrike Koehl; Katherina Sewald
Journal:  Front Bioeng Biotechnol       Date:  2022-03-02

Review 3.  Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.

Authors:  Yuan Zhang; Juhura G Almazi; Hui Xin Ong; Matt D Johansen; Scott Ledger; Daniela Traini; Philip M Hansbro; Anthony D Kelleher; Chantelle L Ahlenstiel
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

4.  Keeping up with the COVID's-Could siRNA-based antivirals be a part of the answer?

Authors:  Helen Forgham; Aleksandr Kakinen; Ruirui Qiao; Thomas P Davis
Journal:  Exploration (Beijing)       Date:  2022-07-14

Review 5.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 6.  Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm.

Authors:  Mai Abdel Haleem Abusalah; Moad Khalifa; Mohammad A I Al-Hatamleh; Mu'taman Jarrar; Rohimah Mohamud; Yean Yean Chan
Journal:  J Pers Med       Date:  2022-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.